The certainties and the uncertainties of ductal carcinoma in situ

Journal of the National Cancer Institute

Volumn 96, Issue 6, 2004, Pages 424-425

  Morrow, Monica ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

AXILLARY LYMPH NODE; BREAST BIOPSY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; EDITORIAL; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE RISK; SENTINEL LYMPH NODE BIOPSY; BREAST TUMOR; DECISION MAKING; DISEASE COURSE; FEMALE; INCIDENCE; LYMPHADENECTOMY; METHODOLOGY; NOTE; PAGET NIPPLE DISEASE; PATIENT PARTICIPATION; PATIENT SATISFACTION; TUMOR RECURRENCE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DECISION MAKING; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; MAMMOGRAPHY; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; PATIENT PARTICIPATION; PATIENT SATISFACTION;

EID: 1642387888     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh088     Document Type: Editorial

References (17)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics 2003. CA Cancer J Clin 2003;53:5-26.
2. Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004;96:443-8.
3. Jackman RJ, Burbank F, Parker SH, Evans WP 3rd, Lechner MC, Richardson TR, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001;218:497-502.
4. Hoorntje LE, Schipper ME, Peeters PH, Bellot F, Storm RK, Borel Rinkes IH. The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: Causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol 2003;10:748-53.
5. Holland R, Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: Mammographic-pathologic correlation. Semin Diagn Pathol 1994;11:181-92.
6. Morrow M, Bucci C, Rademaker A. Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg 1998;186:269-74.
7. Winchester DP, Strom EA. Standard for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast. CA Cancer J Clin 1998;48: 108-28.
8. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998;16:441-52.
9. Solin LJ, Kurtz J, Fourquet A, Amalric R, Recht A, Bornstein BA, et al. Fifteen year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996;14:754-63.
10. Ward BA, McKhann CF, Ravikurmar TS. Ten-year follow-up of breast carcinoma in situ in Connecticut. Arch Surg 1992;127:1392-5.
11. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project. In: Silverstein MJ, editor. Ductal carcinoma in situ of the breast. 2nd ed. Philadelphia (PA): Lippincott, Williams & Wilkins; 2002. p. 432-46.
12. Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A 2003;100:5974-9.
13. Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, et al. Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res 2003;1:362-75.
14. Rakovitch E, Franssen E, Kim J, Ackerman I, Pignol JP, Pazat L, et al. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 2003;77:285-93.
15. De Morgan S, Redman S, White KJ, Cakir B, Boyages J. "WEll, have I got cancer or haven't I?" The psycho-social issues for women diagnosed with ductal carcinoma in situ. Health Expect 2002;5:310-8.
16. Katz SJ, Lantz PM, Zemencuk JK. Correlates of surgical treatment type for women with noninvasive and invasive breast cancer. J Womens Health Gend Based Med 2001;10:659-70.
17. Cook RR, Delongchamp RR, Woodbury M, Perkins LL, Harrison MC. The prevalence of women with breast implants in the United States-1989. J Clin Epidemiol 1995;48:519-25.